Hyponatremia Workup
The workup for hyponatremia should begin with measuring serum and urine osmolality, urine sodium concentration, serum uric acid, and a systematic assessment of extracellular fluid (ECF) volume status—physical examination alone is inadequate for volume assessment and should be supplemented with objective measures. 1
Initial Laboratory Assessment
When serum sodium is <131 mmol/L (or <135 mmol/L per broader definitions), obtain the following tests immediately:
- Serum osmolality - to confirm hypotonic hyponatremia and exclude pseudohyponatremia from hyperglycemia or hypertriglyceridemia 1
- Urine osmolality - essential for determining if ADH activity is appropriate
- Urine sodium concentration - critical for distinguishing causes
- Serum uric acid - levels <4 mg/dL have 73-100% positive predictive value for SIADH 1
- Urine electrolytes including fractional excretion of sodium and urea 1
Volume Status Assessment: The Critical Distinction
Physical examination alone has only 41% sensitivity for determining volume status and cannot be relied upon as the sole method 1. The guidelines emphasize that ECF status is the key to distinguishing between SIADH and cerebral salt wasting (CSW), which have opposite treatments 1.
Objective Volume Assessment Methods:
Central venous pressure (CVP) measurement:
- CVP <5-6 cm H₂O indicates hypovolemia (suggests CSW or volume depletion)
- CVP 6-10 cm H₂O indicates normovolemia (suggests SIADH)
- CVP >10 cm H₂O indicates hypervolemia 1
Point-of-care ultrasonography - recommended as an adjunct to physical assessment 2
Clinical Parameters to Document:
- Mucosal hydration and skin turgor
- Jugular vein distention
- Orthostatic pulse changes (≥10% increase when upright)
- Orthostatic blood pressure changes (≥10% decrease when upright)
- However, remember these have poor sensitivity when used alone 1
Diagnostic Algorithm Based on Urine Studies
Urine Sodium Interpretation:
- Urine Na <30 mmol/L: 71-100% positive predictive value that isotonic saline will increase serum sodium—suggests hypovolemic hyponatremia from extrarenal losses 1
- Urine Na >30 mmol/L with natriuresis: Indicates either SIADH or CSW (after excluding diuretic use) 1
Distinguishing SIADH from CSW:
This is the most challenging differential in neurosurgical patients but critical because treatments are opposite:
SIADH characteristics:
- Normovolemic (CVP 6-10 cm H₂O)
- Urine osmolality inappropriately high relative to serum
- Urine Na typically >30 mmol/L
- Serum uric acid <4 mg/dL
- Low fractional excretion of urea
CSW characteristics:
- Hypovolemic (CVP <5-6 cm H₂O)
- Urine Na >30 mmol/L despite volume depletion
- Responds to saline administration
- Higher fractional excretion of sodium
Additional Workup Considerations
Rule out these conditions before diagnosing SIADH:
- Thyroid disease (TSH)
- Adrenal insufficiency (cortisol, ACTH stimulation test if indicated)
- Diuretic use (medication review)
- Polydipsia (fluid intake history)
In hypervolemic patients, evaluate for:
- Cirrhosis (liver function tests, imaging)
- Congestive heart failure (BNP, echocardiography)
- Renal failure (creatinine, GFR)
Important Caveats
ADH levels have limited diagnostic value and should not be routinely measured—SIADH has been documented even with undetectable ADH levels, and the "appropriateness" of ADH levels remains poorly defined 1. Similarly, natriuretic peptides show conflicting data and are not recommended for routine workup 1.
Saline responsiveness testing can be diagnostic: Some experts recommend administering isotonic saline and measuring urinary sodium excretion to determine the cause, though this approach was developed primarily for non-neurosurgical patients 1.
Clinical Context Matters
The workup intensity should match the severity: Patients with serum sodium <125 mmol/L or those with severe symptoms (confusion, seizures, altered consciousness) require immediate intervention and cannot wait for complete diagnostic workup 3, 4. In these cases, treatment should not be delayed while pursuing a diagnosis.
Recent data shows that 65.5% of hospitalized patients with profound hyponatremia receive the minimum recommended diagnostic workup, and those who receive proper workup are significantly more likely to receive appropriate treatment (91.9% vs 75.8%) 5. This emphasizes the importance of systematic evaluation even in acute settings.